(Q43874860)

27 November 2017

The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats (English)

1 reference

27 November 2017

2

1 reference

27 November 2017

Kei Kamide

1

1 reference

27 November 2017

Jitsuo Higaki

3

1 reference

27 November 2017

Atsunori Okamura

4

1 reference

27 November 2017

Michiko Nagai

5

1 reference

27 November 2017

Kouichi Moriguchi

6

1 reference

27 November 2017

Mitsuru Ohishi

7

1 reference

27 November 2017

Noriyuki Satoh

8

1 reference

27 November 2017

Michael L Tuck

9

1 reference

27 November 2017

Toshio Ogihara

10

1 reference

27 November 2017

1 January 2002

1 reference

Journal of Clinical Hypertension

27 November 2017

1 reference

27 November 2017

15

1 reference

27 November 2017

66-71

1 reference

27 November 2017

1 Pt 1

1 reference

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

Fructose-induced insulin resistance and hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

Insulin resistance and cardiovascular complications in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

Role of the sympathetic nervous system in blood pressure maintenance in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

Impaired in vivo adrenergic responses in diet-induced hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

Insulin insensitivity in nonobese, nondiabetic essential hypertension and its improvement by an alpha 1-blocker (bunazosin)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

AT1 receptor density changes during development of hypertension in hyperinsulinemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

Insulin-mediated growth in aortic smooth muscle and the vascular renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902232-4

7 January 2021

10.1016/S0895-7061(01)02232-4

Identifiers

DOI

1 reference

27 November 2017

1 reference